期刊文献+

草酸铂联合5-氟脲嘧啶和亚叶酸钙双周疗法治疗晚期大肠癌的临床观察 被引量:1

The clinical observation of semimonthly oxalipclation combined with 5-fu and leucovorin in treatment of advanced colorectal cancer
下载PDF
导出
摘要 目的评价草酸铂联合5-氟脲嘧啶和亚叶酸钙双周疗法治疗晚期大肠癌的疗效及毒副反应。方法40例晚期大肠癌患者采用双周疗法:草酸铂100mg/m^2,静脉滴注2小时,第1天;亚叶酸钙200mg/m^2,静脉滴注2小时,第1天;5-氟脲嘧啶400mg/m^2于亚叶酸钙滴完后静脉推注,第1天;再用5-氟脲嘧啶2500mg/m^2注入化疗泵,持续灌注48小时。以上方案每2周重复1次,每2次为1个疗程。所有患者进行2-6个疗程治疗。结果40例患者中完全缓解(CR)4例,部分缓解(PR)15例,稳定(SD)16例,进展(PD)5例,总有效率为47.5%。主要毒副反应为外周神经感觉异常,恶心、呕吐和骨髓抑制等。结论草酸铂联合5-氟脲嘧啶和亚叶酸钙双周疗法治疗晚期大肠癌有较好的近期疗效,毒副反应能为患者耐受,值得临床推广应用。 Objective To evalute the efficacy and the oxicity reaction of semi-monthly oxaiipclation combined with 5-Fu and leucovorin in treatment of advanced colorectal cancer. Methods Forty patients with advanced colorectal cancer received semimonthly combined chemotherapy of L-OHP(100mg/m^2, iv. gtt for 2h, d1) in fusion followed by 2-hour in fusion of CF(200mg/m^2, iv. gtt, d1) then intravenous bolus of 5-Fu 400mg/m^2, then 48-hour infusion of 5-Fu^2 500mg/m^2 using an ambulatory pump. The treatment schedule was recycled every 14 days. One cycle consisted of twice chemotherapy regimens. The curative effect was evaluated two weeks later,and the response for effective patients were confirmed four weeks later. Results The total response rate was 47.5% in which CR 4 cases, PR 15cases, SD 16cases and PD 5cases of forty patients. The major toxic effects were neuro-sensory toxicity, mucositis, nausea and vomiting, bone marrow suppression etc. Conelusions Semimonthly L-OHP combined with 5-Fu and leucovorin regimen is effective in treatment of advanced colorectal cancer, and its toxicity reaction is tolerable.
出处 《国际医药卫生导报》 2009年第2期50-52,共3页 International Medicine and Health Guidance News
关键词 草酸铂 5-氟脲嘧啶 亚叶酸钙 晚期大肠癌 Oxalipclation 5-Fu Leucovorin Treatment of advanced colorectal cancer
  • 相关文献

参考文献6

二级参考文献13

  • 1管忠震,何友兼,刘茂珍,周中梅.大剂量醛氢叶酸合并氟脲嘧啶(HDCF/5Fu)治疗晚期胃肠道癌的探讨[J].癌症,1989,8(6):421-424. 被引量:82
  • 2李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 3孙燕,临床肿瘤内科手术 第3版(第3版),1996年,33-101,214-215页
  • 4Ehrlichman C,Proc Am Soc Clin,1986年,5期,82页
  • 5Seymour MT,Stenning SP,Cassidy J. Attitudes and pratice in the management of metastatic colorectal cancer in Britain .Colorectal cancer working party of the UK medical research council [J]. Clin Oncol, 1997,9(4):248-251.
  • 6Bleiberg H. Oxaloplatin (L-OHP):A new reality in colorectal cancer [J].Br J Cancer ,1998,77(Suppl 4):1-3.
  • 7Raymond E,Buquet-Fagot C,Djelloul S, et al.Antitumor actirity of oxaliplation in conbiration with 5-fluorouracil and thy midylate synthase inhibifor AG337 in human colon ,breast and ovarian[J]. Anticancer Drugs ,1997,8(9):876-885.
  • 8Raymond E, Faivre S, Woynarowski JM,et al .Oxaliplatin: mechanism of action and antineoplastin [J].Semin Oncol ,1998,25(suppl 5):4-12.
  • 9Beliberg H,De Gramont A.Oxaliplatin plus 5-fluorouracil[J].Semin Onclol,1998,25(2,suppl 5):32-39.
  • 10De Gramont A,Figer A,Seymonr M,et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer[J] .J Clin Oncol ,2000,18(12):2968-2947.

共引文献574

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部